Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12.
about
A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challengesTrials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine.Routine dyspnea assessment and documentation: Nurses' experience yields wide acceptance.Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.An integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesStructural brain changes related to disease duration in patients with asthma.Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease.Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study.Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.Descriptors of breathlessness in children with persistent asthma.Assessment of dyspnea in asthma: validation of The Dyspnea-12.Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease.Validation of a three-factor measurement model of dyspnea in hospitalized adults with heart failure.Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?A randomised controlled trial of supplemental oxygen versus medical air during exercise training in people with chronic obstructive pulmonary disease: supplemental oxygen in pulmonary rehabilitation trial (SuppORT) (Protocol).Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.Reliability and validity of the multidimensional dyspnea profileManagement of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial.Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPDValidity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung.Development of a dyspnoea word cue set for studies of emotional processing in COPD.Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Development and validity testing of an IPF-specific version of the St George's Respiratory QuestionnaireDevelopment of a Barthel Index based on dyspnea for patients with respiratory diseases.Protocol of the PLeural Effusion And Symptom Evaluation (PLEASE) study on the pathophysiology of breathlessness in patients with symptomatic pleural effusions.Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension.Nonpharmacological interventions for managing respiratory symptoms in lung cancer.Weighing up the evidence -- a systematic review of measures used for the sensation of breathlessness in obesity.Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.Opioids for chronic refractory breathlessness: right patient, right route?Prevalence and assessment of breathlessness in the clinical setting.Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research.Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?Managing breathlessness: a palliative care approach.Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.Pathophysiology of dyspnea in COPD.COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.
P2860
Q26992071-97A7F360-DB06-439F-B2B7-01A5F1D872C4Q30664694-41765735-B0D9-4B5C-885E-ECF79DF9C826Q30835043-83418E2D-C8FE-41F6-9A08-A3CFA95E2CFFQ31094114-1506569C-072F-47CB-8D3A-CCC98A7C42B8Q33738878-02421927-9DD7-417E-A45E-B78EA1C48154Q33766956-6BFE0111-E024-4256-8E5F-34A070C4CF1BQ34008931-5B9533D3-7826-4D5D-8C5D-30D442A76C40Q34037320-F4ED14FA-FE7C-4503-8760-2C2498623654Q34280516-72643CA3-05B9-4ABE-A669-8DD69AAF4A27Q34419914-869946BA-390D-4E71-A844-48C3658366E0Q34559800-588C5463-F028-4FAA-8954-518F05664111Q34764568-6F7937B7-DE45-46FA-87C6-E6261F41CB0DQ35146573-D49C3A10-9A15-4A43-BBD1-F0FCB25D2147Q35222196-01016195-CA13-45C3-B082-E397E29148ADQ35478473-05D8AD9B-4136-4F41-B8E7-2E6C3CF4A53DQ35604997-A6B49300-D176-4F87-B680-61C0C8317D4FQ35914788-9BB0F37F-7FB0-44BC-8AF3-0F27D65BE3B0Q35991034-4BCB4857-73DA-4CE1-A8E0-744ED5275B98Q36009070-A70507CF-E2B6-4881-AFC0-93CFCD332DB3Q36095774-36BCE757-F9A3-488F-AE99-609385B5D2B8Q36125226-FD40FDB3-32DB-4210-8C7C-EFFE32C04377Q36330440-C3E4ADAD-FA8B-4300-99DF-AB4EA96B67C6Q36587548-C47BE5C2-62AC-4591-B7A1-80CE4DB1F421Q36726418-79288DC4-55E2-4007-A91B-6F1BA709635FQ36969030-25A8DC0C-CE3F-41C5-B9CB-F26E4167F3D7Q37003158-28C8C291-5828-400D-B95E-BB93531DF2F2Q37177617-6D6FD93E-C653-44CC-9F15-60805D59922CQ37632952-8FFC52C6-EFAB-49C7-AB98-F2E7D7AFC3B3Q37676356-518A8902-1173-497F-A836-E4520A73482FQ37997540-EA13F424-242E-4C79-93D8-1ADDB7ACFCFDQ38005244-22618FC8-6E5C-4EAA-8A15-0028B20BEE38Q38055149-8E9392E5-B117-41FB-8108-CC25A16DC143Q38170325-2DBEA36C-CDFE-458A-B707-265233962743Q38180711-10F94D46-B011-4391-9377-8FDF17CCE83BQ38384866-F198A077-9BAE-455F-A91E-BC29633D82F0Q38711045-C134E735-8A37-47BC-893F-8CAAD920F815Q38800285-509D705B-E8E2-4B21-9CDB-8DEE6A22B226Q39113817-BA244FA6-17C6-441E-8616-04CA0A71E7BEQ39170919-26B6D6AB-B62C-4ECD-BF75-25A31C137855Q39177038-6B6E2B04-45E0-41A1-9ADA-86EE9B239F79
P2860
Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@en
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@nl
type
label
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@en
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@nl
prefLabel
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@en
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@nl
P2093
P2860
P356
P1433
P1476
Quantification of dyspnoea usi ...... al testing of the Dyspnoea-12.
@en
P2093
C Shuldham
S H Moosavi
P2860
P356
10.1136/THX.2009.118521
P407
P577
2009-12-08T00:00:00Z